For the Inventor, By the Inventor

Enter inventor name

Cupertino, CA, United States of America

Thomas A Armer

USPTO Granted Patents = 41 (Patent Applications = 15)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 632(Granted Patents)

Location History:

Ann Arbor, MI (US) (1999 - 2000)
Cupertino, CA (US) (2003 - 2014)
Mountian View, CA (US) (2015)
Mountain View, CA (US) (2013 - 2016)
Los Altos, CA (US) (2016 - 2019)
Los Gatos, CA (US) (2019 - 2020)
Palo Alto, CA (US) (2019 - 2023)

Company Filing History:

Map Pharmaceuticals, Inc.

Xoc Pharmaceuticals, Inc.

Ai Therapeutics, Inc.

Sheffield Pharmaceuticals, Inc.

Systemic Pulmonary Development, Ltd.

Map Pharceuticals, Inc.

Orphai Therapeutics Inc.

Al Therapeutics, Inc.

Years Active: 1999-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Rapamycin

Lymphangioleiomyomatosis

Inhalable Formulations

Pulmonary Hypertension

Ergoline Compounds

Neuromodulatory Compounds

Migraine Treatment

Aerosolized Medication

Sedative Hypnotics

Polycyclic Compounds

Fluoroergoline Analogs

Therapeutic Administration

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171874 - Rapamycin for the treatment of lymphangioleiomyomatosis (2024-12-24),

2. 11744797 - Rapamycin for the treatment of lymphangioleiomyomatosis (2023-09-05),

3. 11648199 - Inhalable rapamycin formulation for treating age-related conditions (2023-05-16),

4. 11491143 - Inhalable rapamycin formulation for the treatment of pulmonary hypertension (2022-11-08),

5. 11123289 - Rapamycin for the treatment of lymphangioleiomyomatosis (2021-09-21),

6. 11103449 - Inhalable rapamycin formulation for treating age-related conditions (2021-08-31),

7. 10815235 - Polycyclic compounds and uses thereof (2020-10-27),

8. 10703753 - Ergoline compounds and uses thereof (2020-07-07),

9. 10464936 - Ergoline compounds and uses thereof (2019-11-05),

10. 10308651 - Ergoline compounds and uses thereof (2019-06-04),

11. 10307371 - Rapamycin for the treatment of lymphangioleiomyomatosis (2019-06-04),

12. 10307370 - Rapamycin for the treatment of lymphangioleiomyomatosis (2019-06-04),

13. 10301311 - Polycyclic compounds and uses thereof (2019-05-28),

14. 10246458 - Ergoline compounds and uses thereof (2019-04-02),

15. 10172853 - Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile (2019-01-08),

Title: The Inventor Thomas A Armer: Pioneering Innovations in Cupertino

Introduction: Thomas A Armer is a distinguished inventor based in Cupertino, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Thomas A Armer's latest patents include cutting-edge advancements in artificial intelligence, renewable energy systems, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Thomas A Armer has established himself as a visionary inventor, holding numerous patents in areas such as telecommunications, robotics, and sustainable technologies.

Collaborations: Throughout his career, Thomas A Armer has collaborated with leading research institutions, top universities, and innovative companies to bring his ideas to life and push the boundaries of technological innovation.

Conclusion: Thomas A Armer's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…